Weaning Off Semaglutide: A Step-Down Ladder You Can Actually Track (and Keep Your Muscle)

This article is for information only and is not medical advice. Dosing schedules described here are examples of approaches some clinicians use, not instructions — talk to your prescriber before changing or stopping any medication.

There's no official semaglutide taper, but many clinicians step the dose down gradually to soften the appetite rebound and weight regain that can follow. A common schedule mirrors titration in reverse — 2.4 mg → 1.7 → 1.0 → 0.5 → 0.25 mg, holding each rung roughly 4 weeks — or stretches the interval instead (every 10, then 14 days). Whatever the pace, protect muscle by hitting a daily protein floor (~1.2–1.6 g/kg) and tracking body composition, not just the scale. Decide the plan with your prescriber.

Below is that plan laid out as a ladder you can actually run — dated rungs, an every-other-week variant, a muscle-protection layer, and a restart branch if it doesn't hold. What no taper article can do is decide for you: stopping, tapering, or holding a maintenance dose is a conversation for you and the person who prescribes it.

Is a taper even necessary? Cold turkey vs. step-down

You can stop semaglutide abruptly. It isn't addictive, and quitting doesn't trigger a withdrawal syndrome the way stopping some medications does. So "can you stop semaglutide cold turkey?" has a straightforward answer: physiologically, yes.

The reason clinicians often prefer a step-down isn't withdrawal — it's rebound. Semaglutide works largely by slowing gastric emptying and quieting appetite and "food noise." As the drug leaves your system, those effects fade, and hunger comes back. Semaglutide has a half-life of about one week and takes roughly 4–5 weeks to clear (FDA prescribing information for Ozempic and Wegovy; Novo Nordisk). Cutting the dose gradually is meant to let appetite return in stages rather than all at once, giving your habits time to catch up.

Two honest caveats. First, there is no official taper protocol — nothing in the label tells a prescriber to step you down on a fixed schedule. Tapering is clinical judgement. Second, the evidence that a slow taper beats a clean stop for keeping weight off is still thin. The case for it is mechanistic and pragmatic, not settled. That's exactly why this is a decision to make with your prescriber, not off a chart online.

The semaglutide step-down schedule: a ladder you can track

Here's the part every ranking page describes in prose and never hands you as something you can run. The most commonly reported approach is to reverse the titration ladder you climbed on the way up.

The dose ladder: 2.4 → 1.7 → 1.0 → 0.5 → 0.25 mg

Treat "~4 weeks per rung" as a common pattern, not a rule. In practice, clinicians report holds anywhere from 4 to 8 weeks, and some people spend longer on a lower rung than a higher one. These figures describe approaches practitioners use — they are not label instructions, and your prescriber may set an entirely different pace based on how you respond. If hunger surges hard on a given rung, that's usually the signal to hold longer there rather than push down on schedule.

The every-other-week option: 7 → 10 → 14 days

Instead of dropping the dose, some people stretch the interval between injections while holding the dose steady — for example, moving from every 7 days to every 10, then every 14. It's the same idea (a gentler decline in drug level) approached from a different direction. Some clinicians combine the two: drop to a lower dose first, then stretch the interval on that dose before stopping entirely.

Which route fits you depends on your dose, your pen, and your prescriber's preference. Neither is "official."

Make it trackable: dates and reminders

A ladder is only useful if the next step-down doesn't sneak up on you. The practical move is to give each rung a start date and a "hold ~4 weeks, then reassess" reminder, so the schedule lives on a calendar instead of in your head.

That's the whole idea behind Tiro's dose tracker: it runs the titration ladder in reverse, so your step-down is dated, reminder-able, and logged alongside how you actually felt on each rung. Set your step-down reminders once and let the schedule you agreed with your prescriber run itself.

Protect your muscle on the way down

Here's the gap almost no taper page fills. Everyone says the weight you regain is "mostly fat, not muscle." Fewer tell you how to confirm you're holding onto lean mass. And there's a real reason to care: in body-composition sub-analyses of GLP-1 weight loss, a meaningful share of the weight lost — in some studies roughly a quarter to a third — has been lean mass rather than fat. The taper window is your chance to defend that muscle.

Hit a protein floor (~1.2–1.6 g/kg/day)

Reframe "eat more protein" as a hard daily floor rather than a vague goal. Guidance for adults losing weight lands higher than the general baseline: roughly 1.2–1.6 g of protein per kg of body weight per day, versus the general adult reference of about 0.75–0.8 g/kg (the ISSN position stand on protein and exercise; the British Dietetic Association). Spreading it across the day in 20–40 g servings per meal supports muscle-protein synthesis better than loading it all at dinner.

There's a small silver lining to the taper here: as appetite returns, hitting that floor gets easier than it was at peak dose, when even a chicken breast felt like a chore. Pair the protein with resistance training 2–3 times a week — the combination, not either alone, is what the evidence points to for preserving lean mass during weight loss.

Tiro's signature view is a daily protein floor with a running per-meal bar, so you can see whether today clears your number before dinner — not after.

Verify it: track body composition, not just the scale

The scale can't tell muscle from fat, and during a taper that distinction is the whole game. Watch body-fat percentage, waist and other measurements, progress photos, and a 3D body scan through the step-down, so a stable or slightly rising scale weight doesn't panic you when your waist and body-fat are holding.

This matters because the reassuring line — that regain is mostly fat — is only reassuring if you can see it happening. In the SURMOUNT-4 trial (JAMA, 2024) and the STEP 1 extension (Wilding et al., Diabetes, Obesity and Metabolism, 2022), regain after stopping was substantial, but tracking body composition is how you verify your own trend rather than assuming it. Watch lean mass with a body scan, not just the scale, and let the measurements tell the real story.

Taper vs. stay on a maintenance dose

The fork most articles skip: for many people, the honest choice isn't "taper vs. stop" but "taper vs. keep going on less." GLP-1 medications are studied and, increasingly, prescribed as long-term therapy — a lower ongoing maintenance dose is a legitimate path, not a failure to quit.

The data behind that framing is sobering and worth stating plainly. In the STEP 1 extension (Wilding et al., Diabetes, Obesity and Metabolism, 2022), participants regained a large share of lost weight in the year after stopping semaglutide — roughly two-thirds of it, on average. In SURMOUNT-4 (JAMA, 2024), people who switched from tirzepatide to placebo regained substantially, while those who continued treatment kept losing; most who stopped regained a meaningful fraction of their loss within a year.

None of that decides anything for you. It's context for a conversation. Some people taper to zero and hold their result with habits; others do best on a low maintenance dose indefinitely. Tiro tracks either path — the dose ladder runs in both directions, and the protein and body-composition views work the same whether you're at 0.25 mg or off entirely.

What to expect after your last dose: the appetite-return timeline

Because semaglutide has a roughly one-week half-life and clears over about 4–5 weeks (FDA prescribing information; Novo Nordisk), appetite and food noise typically ramp back over about weeks 2–5 after your final injection — not on day 3, and not overnight. Knowing the curve helps you read the return as expected physiology rather than a personal failing.

One clarification that trips people up: nausea, the most common GI side effect on semaglutide, generally eases on a stable dose — it's a dose-change symptom, not a stopping symptom. Coming off is far more likely to bring hunger back than to make you queasy.

The useful habit here is to measure the rebound instead of bracing for it. A weekly food-noise check-in — rating how loud your appetite is and where it's showing up — turns a vague fear into a trend line you can act on. Log side effects and get "is this normal?" tips as they come, and read the appetite return against your last-dose date instead of guessing. If food noise is climbing hard, our guide on when food noise comes back on GLP-1s covers what to do next.

If it doesn't hold: restarting means re-titrating

Sometimes the taper doesn't stick, and — with your clinician — you restart. The key thing to know: you generally can't jump back to your old top dose. Restarting means re-titrating from a low rung (typically 0.25 or 0.5 mg) and ramping up again, because your tolerance to the drug's GI effects fades once you've been off it (Novo Nordisk prescribing information). Resuming at 2.0 mg after a break is a recipe for the nausea you escaped the first time.

This is where the ladder earning its keep runs in reverse-of-the-reverse. Tiro's dose tracker ramps back up on the same rungs, so a restart is just the ladder pointed the other way — with reminders. On the way back up, log GI symptoms and rotate injection sites (the app's site heatmap flags where you last injected) so you're not re-titrating blind.

UK note: stopping Mounjaro / tirzepatide

Everything above applies to tirzepatide (Mounjaro), the dominant weight-loss brand in the UK. The step-down logic is the same, and SURMOUNT-4 (JAMA, 2024) is the tirzepatide-specific evidence on regain after stopping. If you're coming off after a short course — the "stopping Mounjaro after 3 months" scenario — or leaving an NHS or private clinic (Voy, Numan, CheqUp, SimplePharmacy and others), agree the step-down plan before your last prescription, and check what NICE guidance and the NHS advise for your situation. Continuity of a plan matters more than the exact rung. For a deeper look at the muscle question specifically, see Mounjaro vs. Ozempic: muscle loss.

Frequently asked questions

Do you have to wean off semaglutide, or can you just stop? You can stop abruptly — there's no withdrawal syndrome. Many clinicians taper anyway to soften the appetite rebound as the drug clears. There's no official protocol, so decide the approach with your prescriber.

What's a typical semaglutide taper schedule? A common pattern reverses titration — 2.4 → 1.7 → 1.0 → 0.5 → 0.25 mg, holding each rung about 4 weeks — or stretches the interval (7 → 10 → 14 days). These are clinician-reported approaches, not label instructions.

How do I keep muscle when coming off semaglutide? Hit a protein floor of roughly 1.2–1.6 g/kg per day, do resistance training 2–3 times a week, and track body-fat percentage and measurements so you can confirm you're preserving lean mass rather than just watching the scale.

Will I regain the weight after I stop? Withdrawal studies (STEP 1 extension; SURMOUNT-4) show most people regain a large share of lost weight within a year off-drug. A gradual taper plus protein and strength habits may help, but results vary — it's not a guarantee.

How long until my appetite comes back? As the roughly one-week-half-life drug clears over about 4–5 weeks, appetite typically returns over about weeks 2–5 after your last dose.

What if I need to restart semaglutide? You generally re-titrate from a low dose (0.25 or 0.5 mg) and ramp up again rather than resuming your previous top dose, to limit nausea (Novo Nordisk prescribing information).

Track your taper

Tiro is a tracking companion for a taper you plan with your prescriber — not a treatment, and not a promise about your results. If you're stepping down, set your dose reminders, hold your protein floor, and watch your body composition so you're keeping muscle, not just watching the scale. See what Tiro tracks.

Sources

• FDA prescribing information for Wegovy (semaglutide) — Novo Nordisk
• FDA prescribing information for Ozempic (semaglutide) — Novo Nordisk
• Wilding JPH et al., "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension," Diabetes, Obesity and Metabolism, 2022
• Aronne LJ et al., "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4)," JAMA, 2024
• International Society of Sports Nutrition (ISSN) position stand on protein and exercise
• British Dietetic Association (BDA) — protein guidance
• NICE guidance and NHS — weight-management medication (UK)